Renin-and non-renin–mediated antihypertensive actions of converting enzyme inhibitors

RM Zusman - Kidney international, 1984 - Elsevier
Discussion DR. RANDALL M. ZUSMAN (Director, Hypertension Division, Cardiac Unit,
Massachusetts General Hospital, and Assistant Professor of Medicine, Harvard Medical …

Angiotensin-converting enzyme inhibitors: biochemical properties and biological action

MA Ondetti, DW Cushman, RL Soffer - Critical Reviews in …, 1984 - Taylor & Francis
Careful scrutiny of scientific records can show that the connection between the kidney and
hypertension had been discovered early in the 19th century, but undoubtedly it is the …

[引用][C] Converting enzyme inhibitors in cardiovascular therapy: current status and future potential

T Unger, P Gohlke - Cardiovascular research, 1994 - academic.oup.com
Thomas Unger and Peter Gohlke he renin-angiotensin system (fig I) is a major
cardiovascular control mechanism. The ingenious T induction of secondary hypertension in …

Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical …

RM Zusman - American journal of kidney diseases: the official …, 1987 - europepmc.org
The renin-angiotensin-aldosterone system plays an integral role in the control of BP and is
mediated by enzymatic transformation of substances in the renin-angiotensin cascade …

Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension

MA Ondetti, DW Cushman - Journal of medicinal chemistry, 1981 - ACS Publications
The renin-angiotensin system is one of the humoral mechanisms involved in the regulation
of blood pressure. Even though thepreliminary investigations can be traced as far back as …

[PDF][PDF] Angiotensin‐converting enzyme inhibitors: medicinal chemistry and biological actions

EW Petrillo Jr, MA Ondetti - Medicinal research reviews, 1982 - natmedlib.uz
The beginning of the 1980s may well be remembered as a turning point in the treatment of
hypertension, one of the most common of man's afflictions.'In 1980 and 1981, the first …

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

DB Case, SA Atlas, JH Laragh, JE Sealey… - Captopril and …, 1980 - Springer
Although the role of the renin-angiotensin system in the pathogenesis of hypertension
remains a subject of active investigation and debate, there is increasing recognition that …

Converting enzyme inhibition and the kidney.

LG Meggs, NK Hollenberg - Hypertension, 1980 - Am Heart Assoc
We review information on the renal response to converting enzyme inhibition, and attempt to
evaluate the evidence that a reduction in angiotensin II formation is responsible for the renal …

Inhibitors of renin as potential therapeutic agents

JM Wood, JL Stanton, KG Hofbauer - Journal of enzyme inhibition, 1987 - Taylor & Francis
The importance of the renin-angiotensin system (RAS) in blood pressure (BP) regulation
and sodium homeostasis has been revealed by extensive experimental and clinical studies …

Pharmacology of renin inhibitors and their application to the treatment of hypertension

JM Wood, F Cumin, J Maibaum - Pharmacology & therapeutics, 1994 - Elsevier
Several different strategies have been followed to block the activity of renin, the enzyme
catalyzing the first and rate-limiting step in the renin-angiotensin cascade. The unique …